Tumor-infiltrating lymphocytes (TIL) therapy represents a groundbreaking advancement in treating of solid tumors, leveraging the body's immune system to target and eliminate cancerous cells. This therapy involves extracting TILs from a patient's tumor, expanding them ex vivo, and infusing them to fortify the body's natural defenses against malignancies. Recent breakthroughs underscore the therapy's potential to transform oncological care, with numerous studies reporting high response rates and prolonged overall survival across diverse tumor typ
